Type I interferon pathway genetic variants in severe COVID-19

被引：4

作者：

Montenegro, A. F. L. ^{[1
]}

Clementino, M. A. F. ^{[2
]}

Yaochite, J. N. U. ^{[1
]}

机构：

[1] Univ Fed Ceara UFC, Fac Farm Odontol & Enfermagem, Dept Anal Clin & Toxicol, Lab Imunol Celular & Mol, Rua Pastor Samuel Munguba 1210, Fortaleza, Ceara, Brazil

[2] Univ Fed Ceara UFC, Lab Toxinol Mol, NUBIMED Nucleo Biomed, Fortaleza, Ceara, Brazil

来源：

VIRUS RESEARCH | 2024年 / 342卷

关键词：

COVID-19; Type I interferon; Single nucleotide polymorphisms; SUSCEPTIBILITY; IMMUNITY; INNATE;

D O I：

10.1016/j.virusres.2024.199339

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2. According to the World Health Organization (WHO), there have been over 760 million reported cases and over 6 million deaths caused by this disease worldwide. The severity of COVID-19 is based on symptoms presented by the patient and is divided as asymptomatic, mild, moderate, severe, and critical. The manifestations are interconnected with genetic variations. The innate immunity is the quickest response mechanism of an organism against viruses. Type I interferon pathway plays a key role in antiviral responses due to viral replication inhibition in infected cells and adaptive immunity stimulation induced by interferon molecules. Thus, variants in type I interferon pathway's genes are being studied in different COVID-19 manifestations. This review summarizes the role of variants in type I interferon pathway's genes on prognosis and severity progression of COVID-19.

引用

页数：9

共 84 条

[1]

Abdelhafez Mohammad, 2023, Interdiscip Perspect Infect Dis, V2023, P9551163, DOI 10.1155/2023/9551163

[2] Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome [J].

Abolhassani, Hassan ;

Landegren, Nils ;

Bastard, Paul ;

Materna, Marie ;

Modaresi, Mohammadreza ;

Du, Likun ;

Aranda-Guillen, Maribel ;

Sardh, Fabian ;

Zuo, Fanglei ;

Zhang, Peng ;

Marcotte, Harold ;

Marr, Nico ;

Khan, Taushif ;

Ata, Manar ;

Al-Ali, Fatima ;

Pescarmona, Remi ;

Belot, Alexandre ;

Beziat, Vivien ;

Zhang, Qian ;

Casanova, Jean-Laurent ;

Kampe, Olle ;

Zhang, Shen-Ying ;

Hammarstrom, Lennart ;

Pan-Hammarstrom, Qiang .

JOURNAL OF CLINICAL IMMUNOLOGY, 2022, 42 (03) :471-483

[3] Deleterious single nucleotide polymorphisms (SNPs) of human IFNAR2 gene facilitate COVID-19 severity in patients: a comprehensive in silico approach [J].

Akter, Shamima ;

Roy, Arpita Singha ;

Tonmoy, Mahafujul Islam Quadery ;

Islam, Md Sajedul .

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (21) :11173-11189

[4] Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality [J].

Alghamdi, Jahad ;

Alaamery, Manal ;

Barhoumi, Tlili ;

Rashid, Mamoon ;

Alajmi, Hala ;

Aljasser, Nasser ;

Alhendi, Yaseen ;

Alkhalaf, Hind ;

Alqahtani, Hanadi ;

Algablan, Omer ;

Alshaya, Abdulraham, I ;

Tashkandi, Nabiha ;

Massadeh, Salam ;

Almuzzaini, Bader ;

Ehaideb, Salleh N. ;

Bosaeed, Mohammad ;

Ayoub, Kamal ;

Yezli, Saber ;

Khan, Anas ;

Alaskar, Ahmed ;

Bouchama, Abderrezak .

GENOMICS, 2021, 113 (04) :1733-1741

[5] Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19 [J].

Azkur, Ahmet Kursat ;

Akdis, Mubeccel ;

Azkur, Dilek ;

Sokolowska, Milena ;

van de Veen, Willem ;

Bruggen, Marie-Charlotte ;

O'Mahony, Liam ;

Gao, Yadong ;

Nadeau, Kari ;

Akdis, Cezmi A. .

ALLERGY, 2020, 75 (07) :1564-1581

[6] Association Between BNT162b2 Vaccination and Long COVID After Infections Not Requiring Hospitalization in Health Care Workers [J].

Azzolini, Elena ;

Levi, Riccardo ;

Sarti, Riccardo ;

Pozzi, Chiara ;

Mollura, Maximiliano ;

Mantovani, Alberto ;

Rescigno, Maria .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (07) :676-678

[7] Interferon-inducer antivirals: Potential candidates to combat COVID-19 [J].

Bagheri, Ashkan ;

Moezzi, Seyed Mohammad Iman ;

Mosaddeghi, Pouria ;

Parashkouhi, Sadra Nadimi ;

Hoseini, Seyed Mostafa Fazel ;

Badakhshan, Fatemeh ;

Negahdaripour, Manica .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 91

[8] Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection [J].

Balkhi, Mumtaz Y. .

MOLECULAR IMMUNOLOGY, 2021, 135 :268-275

[9] Autoantibodies against type I IFNs in patients with life-threatening COVID-19 [J].

Bastard, Paul ;

Rosen, Lindsey B. ;

Zhang, Qian ;

Michailidis, Eleftherios ;

Hoffmann, Hans-Heinrich ;

Zhang, Yu ;

Dorgham, Karim ;

Philippot, Quentin ;

Rosain, Jeremie ;

Beziat, Vivien ;

Manry, Jeremy ;

Shaw, Elana ;

Haljasmagi, Liis ;

Peterson, Part ;

Lorenzo, Lazaro ;

Bizien, Lucy ;

Trouillet-Assant, Sophie ;

Dobbs, Kerry ;

de Jesus, Adriana Almeida ;

Belot, Alexandre ;

Kallaste, Anne ;

Catherinot, Emilie ;

Tandjaoui-Lambiotte, Yacine ;

Le Pen, Jeremie ;

Kerner, Gaspard ;

Bigio, Benedetta ;

Seeleuthner, Yoann ;

Yang, Rui ;

Bolze, Alexandre ;

Spaan, Andras N. ;

Delmonte, Ottavia M. ;

Abers, Michael S. ;

Aiuti, Alessandro ;

Casari, Giorgio ;

Lampasona, Vito ;

Piemonti, Lorenzo ;

Ciceri, Fabio ;

Bilguvar, Kaya ;

Lifton, Richard P. ;

Vasse, Marc ;

Smadja, David M. ;

Migaud, Melanie ;

Hadjadj, Jerome ;

Terrier, Benjamin ;

Duffy, Darragh ;

Quintana-Murci, Lluis ;

van de Beek, Diederik ;

Roussel, Lucie ;

Vinh, Donald C. ;

Tangye, Stuart G. .

SCIENCE, 2020, 370 (6515) :423-+

[10] Susceptibility to severe COVID-19 [J].

Beck, David B. ;

Aksentijevich, Ivona .

SCIENCE, 2020, 370 (6515) :404-405

← 1 2 3 4 5 6 7 8 9 →